VEGFA and neoplasm: For example, anti-angiogenic treatment of GBM that blocks vascular endothelial growth factor A (VEGF-A or VEGF), a critical proangiogenic mediator, causes a “normalization” of the vasculature [17] and leads to reduced cerebral edema and improved drug delivery to the tumor [18].